A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON (PALO) FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN MALIGNANT GLIOMA (MG) PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Affronti, ML; Brickhouse, A; Marcello, J; Herndon, J; Reardon, DA; Desjardins, A; Vredenburgh, JJ

Published Date

  • October 1, 2009

Published In

Volume / Issue

  • 11 / 5

Start / End Page

  • 656 - 656

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • Joint Meeting of the Society-forNeuro-Oncology/American-Association-of-Neurological -Surgeons/Congress of Neurological Surgeons

Conference Location

  • New Orleans, LA

Conference Start Date

  • October 22, 2009

Conference End Date

  • October 24, 2009